tailieunhanh - Risk of second primary cancers in cancer patients treated with cisplatin: A systematic review and meta-analysis of randomized studies

Case reports, retrospective analyses, and observational studies have linked the use of cisplatin to increased risk of second cancers, especially life-threatening secondary leukemia. We therefore performed a systematic review and meta-analysis to evaluate the risk of second cancers associated with receipt of cisplatin-based chemotherapy in randomized controlled trials (RCTs). | Risk of second primary cancers in cancer patients treated with cisplatin A systematic review and meta-analysis of randomized studies

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN